Prognostic Value of Serum Markers in Colorectal Cancer
Author Information
Author(s): M Carpelan-Holmstrom, C Haglund, J Lundin, H Alfthan, U-H Stenman, PJ Roberts
Primary Institution: Helsinki University Central Hospital
Hypothesis
The study investigates the prognostic value of preoperative serum concentrations of various tumor markers in colorectal cancer.
Conclusion
CA 242 is a significant predictor of survival in advanced stages of colorectal cancer, while CEA does not provide additional prognostic information.
Supporting Evidence
- CA 242 was the only marker that provided prognostic information within Dukes' B and C colorectal cancer.
- An elevated serum level of any of the investigated tumor markers was strongly related to disseminated disease and poor survival.
- In Dukes' D colorectal cancer, CA 242, TPA, TPS, and hCG showed prognostic value.
Takeaway
Doctors looked at blood tests to see if they could tell how well patients with colon cancer would do after surgery. Some tests worked better than others.
Methodology
Preoperative serum samples were obtained from 251 patients and analyzed for various tumor markers using specific assays.
Limitations
The study did not provide prognostic information for Dukes' A stage.
Participant Demographics
The study included 127 men and 124 women with a median age of 69 years.
Statistical Information
P-Value
p<0.0001
Confidence Interval
(95%) 1.7-3.5
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website